Ofatumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about GlobalPharmacyMeds.to
List of countries where we can ship Ofatumumab:
Latest news releases on Ofatumumab:
Ofatumumab is a human monoclonal antibody which targets an epitope in the CD20 molecule encompassing parts of the small and large extracellular loops.
Find patient medical information for Ofatumumab Intravenous on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Ofatumumab (Arzerra) is an approved leukemia treatment marketed by Novartis and now in Phase 3 clinical tests for relapsing MS.
Ofatumumab. Ofatumumab is a recombinant human mAb directed at CD20, a B cell-specific cell surface molecule of uncertain function. 81 It is approved for treatment of ...
Cases of the steroid-resistant nephrotic syndrome that are resistant to rituximab can be difficult to treat. In this report, ofatumumab, an anti-CD20 monoclonal ...
新着一覧へ ニュース. 2014/6/5. 再発性/難治性CLL患者に対するibrutinib単剤投与はofatumumabに比べ有意な生存利益をもたらす ...
False-positive immunogenicity responses are caused by CD20 + B cell membrane fragments in an anti-ofatumumab antibody bridging assay
Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.
the most important information i should know about rituxan: infusion reactions, severe skin and mouth reactions, hepatitis b virus (hbv) reactivation and progressive ...
Mantle cell lymphoma (MCL) is a rare and incurable subtype of non-Hodgkin’s lymphoma that generally affects older individuals. However, the use of high-dose therapy ...